Search Within

Gregory J Riely

  1. "Andrew Plodkowski"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (7)
Groups
  1. Body Imaging Service (33)
  2. Department of Medicine (33)
  3. Radiology, Department of (33)
  4. Solid Tumor Oncology Division (33)
  5. Thoracic Oncology (33)
  6. Hematology-Oncology Fellows (26)

More Groups

People
  1. Andrew Plodkowski (33)
  2. Charles Rudin (18)
  3. Marc Ladanyi (17)
  4. Mark Kris (17)
  5. Matthew Hellmann (16)
  6. Hira Rizvi (13)

More People

Years
  1. 2023 (5)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (4)
  5. 2019 (5)
  6. 2018 (9)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Journal of Thoracic Oncology (6)
  3. Clinical Cancer Research (5)
  4. Annals of Oncology (4)
  5. Cancer Discovery (2)
  6. JCO Precision Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. American Association for Cancer Research (7)
  3. Elsevier Inc. (7)
  4. Oxford University Press (5)
  5. Elsevier Ireland Ltd. (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (33)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non–small cell lung cancer
    Journal Article

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Rizvi, H.; Elkrief, A.; Luo, J.; Alessi, J. V.; Pecci, F.; Lamberti, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • The GENIE BPC NSCLC cohort: A real-world repository integrating standardized clinical and genomic data for 1,846 patients with non-small cell lung cancer
    Journal Article

    Choudhury, N. J.; Lavery, J. A.; Brown, S.; de Bruijn, I.; Jee, J.; Tran, T. N.; Rizvi, H.; Arbour, K. C.; Whiting, K.; Shen, R.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to anti-PD-(L)1 therapy in patients with advanced non-small cell lung cancer
    Meeting Abstract

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Luo, J.; Alessi, J. V. M.; Pecci, F.; Lamberti, G.; Hong, Lingzhi; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Brief report: Combination of osimertinib and dacomitinib to mitigate primary and acquired resistance in EGFR-mutant lung adenocarcinomas
    Journal Article

    Elkrief, A.; Makhnin, A.; Moses, K. A.; Ahn, L. S.; Preeshagul, I. R.; Iqbal, A. N.; Hayes, S. A.; Plodkowski, A. J.; Paik, P. K.; Ladanyi, M.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Systemic and oligo-acquired resistance to PD-(L)1 blockade in lung cancer
    Journal Article

    Schoenfeld, A. J.; Rizvi, H. A.; Memon, D.; Shaverdian, N.; Bott, M. J.; Sauter, J. L.; Tsai, C. J.; Lihm, J.; Hoyos, D.; Plodkowski, A. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers
    Journal Article

    Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Treatment outcomes and clinical characteristics of patients with KRAS-G12C-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Hellmann, M. D.; Knezevic, A.; Heller, G.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; Arcila, M. E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Deep learning to estimate RECIST in patients with NSCLC treated with PD-1 blockade
    Journal Article

    Arbour, K. C.; Luu, A. T.; Luo, J.; Rizvi, H.; Plodkowski, A. J.; Sakhi, M.; Huang, K. B.; Digumarthy, S. R.; Ginsberg, M. S.; Girshman, J.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Clinical characteristics and anti-PD-(L)1 treatment outcomes of KRAS-G12C mutant lung cancer compared to other molecular subtypes of KRAS-mutant lung cancer
    Meeting Abstract

    Arbour, K. C.; Rizvi, H.; Plodkowski, A. J.; Halpenny, D.; Hellmann, M. D.; Heller, G.; Knezevic, A.; Yu, H. A.; Ladanyi, M.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save